Abstract
The development of protocols to induce a state of durable mixed allogeneic hematopoietic chimerism to confer robust donor-specific transplant tolerance has been a major focus of the transplant community for the past decade. High levels of mixed allogeneic hematopoietic chimerism across a full major histocompatibility complex (MHC) barrier can be achieved by total myeloablation and transfusion of host and donor bone-marrow cells (1) or, as shown more recently, can be achieved with nonmyeloablative preconditioning regimes in combination with donor bone-marrow transfusions (2-4) or transfusion of purified hematopoietic stem cells (HSC) (5-7). Here we illustrate useful experimental techniques for the study of hematopoietic chimerism in rodents by describing a system in which chimerism can be induced using nonmyeloablative conditioning, short-term costimulation blockade, and transplantation of purified or cultured hematopoietic stem cells.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Ildstad, S. T. and Sachs, D. H. (1984) Reconstitution with syngeneic plus allogeneic or xenogeneic bone marrow leads to specific acceptance of allografts or xenografts. Nature 3075947, 168ā170.
Wekerle, T., Sayegh, M. H., Ito, H., et al. (1999) Anti-cd154 or ctla4ig obviates the need for thymic irradiation in a non-myeloablative conditioning regimen for the induction of mixed hematopoietic chimerism and tolerance. Transplantation 689, 1348ā1355.
Wekerle, T., Kurtz, J., Ito, H., et al. (2000) Allogeneic bone marrow transplantation with co-stimulatory blockade induces macrochimerism and tolerance without cytoreductive host treatment. Nat. Med. 64, 464ā469.
Durham, M. M., Bingaman, A. W., Adams, A. B., et al. (2000) Cutting edge: Administration of anti-cd40 ligand and donor bone marrow leads to hemopoietic chimerism and donorspecific tolerance without cytoreductive conditioning. J. Immunol. 1651, 1ā4.
Bachar-Lustig, E., Li, H. W., Marcus, H., and Reisner, Y. (1998) Tolerance induction by megadose stem cell transplants: Synergism between sca-1+ lin-cells and nonalloreactive t cells. Transplant. Proc. 308, 4007ā4008.
Uchida, N., Tsukamoto, A., He, D., et al. (1998) High doses of purified stem cells cause early hematopoietic recovery in syngeneic and allogeneic hosts. J. Clin. Invest. 101(5), 961ā966.
Emmanouilidis, N., Hussain, A., Adams, A. B., et al. (2002) Costimulation Blockade, administration of Busulfan and Infusion of purified Sca1posLinneg bone marrow cells leads to hematopoietic chimerism in a full MHC disparate mouse model. Am. J. Trans. Suppl. 32, 211.
Spangrude, G. J., Heimfeld, S., and Weissman, I. L. (1988) Purification and characterization of mouse hematopoietic stem cells. Science 2414861, 58ā62.
Adams, A. B., Durham, M. M., Kean, L., et al. (2001) Costimulation blockade, busulfan, and bone marrow promote titratable macrochimerism, induce transplantation tolerance, and correct genetic hemoglobinopathies with minimal myelosuppression. J. Immunol. 1672, 1103ā1111.
Fraser, C. C., Szilvassy, S. J., Eaves, C. J., and Humphries, R. K. (1992) Proliferation of totipotent hematopoietic stem cells in vitro with retention of long-term competitive in vivo reconstituting ability. Proc. Natl. Acad. Sci. USA 895, 1968ā1972.
Petzer, A. L., Hogge, D. E., Landsdorp, P. M., Reid, D. S., and Eaves, C. J. (1996) Selfrenewal of primitive human hematopoietic cells (long-term-culture-initiating cells) in vitro and their expansion in defined medium. Proc. Natl. Acad. Sci. USA 934, 1470ā1474.
Neben, S., Donaldson, D., Sieff, C., et al. (1994) Synergistic effects of interleukin-11 with other growth factors on the expansion of murine hematopoietic progenitors and maintenance of stem cells in liquid culture. Exp. Hematol. 224, 353ā359.
Koller, M. R., Oxender, M., Brott, D. A., and Palsson, B. O. (1996) Flt-3 ligand is more potent than c-kit ligand for the synergistic stimulation of ex vivo hematopoietic cell expansion. J. Hematother. 55, 449ā459.
Bryder, D. and Jacobsen, S. E. (2000) Interleukin-3 supports expansion of long-term multilineage repopulating activity after multiple stem cell divisions in vitro. Blood 965, 1748ā1755.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
Ā© 2005 Humana Press Inc.
About this protocol
Cite this protocol
Emmanouilidis, N., Larsen, C.P. (2005). Induction of Chimerism and Tolerance Using Freshly Purified or Cultured Hematopoietic Stem Cells in Nonmyeloablated Mice. In: Ludewig, B., Hoffmann, M.W. (eds) Adoptive Immunotherapy: Methods and Protocols. Methods in Molecular Medicineā¢, vol 109. Humana Press. https://doi.org/10.1385/1-59259-862-5:459
Download citation
DOI: https://doi.org/10.1385/1-59259-862-5:459
Publisher Name: Humana Press
Print ISBN: 978-1-58829-406-7
Online ISBN: 978-1-59259-862-5
eBook Packages: Springer Protocols